Trial intelligence / Profile preview

Efficacy of celecoxib in the treatment of bipolar disorder

IRCT201307171556N53Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Sep 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of celecoxib in bipolar disorder (BD), sponsored by Tehran University of Medical Sciences. Started Sep 2013; status: completed.

02

Drugs

celecoxib
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on IRCT201307171556N53.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201307171556N53.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call